Image source: pixelied.com / pixabay.com
Financial analysts from Freedom Broker and Halyk Finance have lauded the financial report of the uranium company "Kazatomprom," particularly noting a positive growth trajectory in revenue. According to Freedom Broker's assessment, while an increase in production costs and a decrease in uranium sales are anticipated, they recommend purchasing Kazatomprom's shares, anticipating the company's ability to rebound to its target metrics. Similarly, Halyk Finance acknowledges that Kazatomprom hasn't fully capitalized on the surging uranium prices, yet they advise investors to buy the company's stocks based on the record-breaking financial results, as reported by broker reviews.
Freedom Broker highlights potential production challenges due to sulfuric acid procurement issues, projecting them to be temporary and affirming Kazatomprom's capability to regain previous production and sales targets. Additionally, experts underscore the company's record revenue of 1.43 trillion tenge, marking a 43%
LATEST NEWS
-
Chaarat Gold Secures Major Funding for Tulkubash Mine in Kyrgyzstan
17/05/2024
-
Polish Government Backs Rolls-Royce Plan to Build Nuclear Power Plants
17/05/2024
-
Court Overturns Illegal Seizure of Solid Metals’ Property in Kazakhstan
17/05/2024
-
EBRD and Kazakhstan Collaborate to Modernize Mining Sector
17/05/2024
